Oral PrEP safety in pregnancy with longitudinal follow-up of children for 36 months

By sjmartinez • March 2, 2025

Joseph Davey D, Malaba TR. Oral PrEP safety in pregnancy with longitudinal follow-up of children for 36 months. Lancet Glob Health. 2025 Mar;13(3):e379-e380. doi: 10.1016/S2214-109X(24)00531-X. PMID: 40021292.

Tags: Infectious Diseases, Publications

Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

Dao KT, D'Assumpcao C, Sharma R, Singh C, Kuran R, Heidari A. Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Cureus. 2025 Feb 24;17(2):e79588.[...]

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Giganti MJ, Chew KW, Moser C, Eron JJ, Pinilla M, Li JZ, Ritz J, Javan AC, Wohl DA, Daar ES, Currier JS, Smith DM, Hughes[...]

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]